Mednet Logo

Why do we tend to boost grade 3 DCIS, but not grade 1 invasive disease?

3 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Cooper Medical School of Rowan University/Cooper University Hospital
Answered on

For the same reason that a surgeon has to re-excise a 1 mm margin in a pure DCIS case, but that same surgeon does not re-excise a 1 mm margin on the DCIS that is associated with an invasive component...because guidelines.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · David Geffen School of Medicine at UCLA
Answered on

I agree with @Dr. First Last. In addition, the calculus for a treatment decision is based on the expected value, which is mathematically a function of both the risk (probability) of an event as well as the significance of the event if it occurred. Biomarker status was not reported in the question, b...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

The risk of local recurrence is a function of grade, age, phenotype, and margin status. More the risk factors, the higher the risk of recurrence, and the rationale for ASTRO's recommendation for boost
https://www.astro.org/Patient-Care-and-Research/Clinical-Practice-Statements/Whole-Breast-Irradiati...

Join for free or sign in to see the full answer